Indigent Breast Ca Pts: More Advanced Disease

Indigent breast cancer patients among all racial and ethnic groups present with more advanced disease compared withnationally reported data

Arpana M. Naik a, Kathy Joseph a, Marcia Harris a, Christine Davis a, Richard Shapiro a and Karen L. Hiotis a

a Department of Surgery, New York University School of Medicine, 550 First Ave., New York, NY 10016, USA

Abstract

Background

This study examines the epidemiologic and pathologic characteristics of indigent breast cancer patients followed up in a public city hospital in comparison to national standards.

Methods

A prospective oncology database was queried to identify all patients presenting with primary breast cancer. Medical records of 188 patients identified between March 1997 and May 2002 were retrospectively reviewed.

Pathologic and epidemiologic data were compared with 1998 data reported by the Surveillance, Epidemiology, and End Results (SEER) program.

Results

Among the patient population 10% were Caucasian, 13% African-American, 49% Hispanic, 25% Chinese, and 6% were of other background.

The majority of patients were uninsured. Indigent patients within each ethnic group presented with more advanced disease when compared with patients reported by SEER.

Conclusions

Indigent patients among all ethnic and racial backgrounds present with more advanced disease when compared with national statistics reported by SEER.

The majority of these patients is uninsured and would benefit from more aggressive education, screening, detection methods, and follow-up.

The American Journal of Surgery, Volume 186, Issue 4, Pages 400-403 (October 2003)


Lifestyle influence/damage P53 gene (tumor suppressor)

University of Dundee, February 2010 British J of Cancer


Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.